Related Experiment Video
Updated: Jun 4, 2026
Cholesterol Efflux Assay
Published on: March 6, 2012
[Effect of apolipoprotein A-I mimetic peptides on cholesterol efflux in RAW264.7 cells]
1Department of Cardiology, Central South University, Changsha 410011, China.
Objective:
To determine the effect and possible mechanism of an apolipoprotein (apo) A-I mimetic peptide, D-4F, on cholesterol efflux in RAW264.7 macrophages.
Methods:
RAW264.7 macrophages were incubated in the medium containing 8-bromo cAMP (8-Br-cAMP, 0.5 mmol/L) and ox-LDL (50 μg/mL) for 24 h. Then various concentrations of D-4F (0-100 μg/mL) or H89 (20 μmol/L, a protein kinase A inhibitor) were added for the purpose of interference. The intracellular cyclic AMP (cAMP) level was determined by enzyme-linked immunoabsobant assay (ELISA). ATP binding cassette transporter A1 (ABCA1) expression in the macrophages was quantitated by real-time PCR and Western blot.
Results:
D-4F significantly increased the cholesterol efflux in both concentration and time-dependent manner accompanied by the increase in the intracellular cAMP level, ABCA1 mRNA and protein expression. The effect of D-4F on cholesterol efflux ABCA1 expression was enhanced by 8-Br-cAMP. Although H89 did not affect the basal cholesterol efflux and ABCA1 expression, it could attenuate the effect of 8-Br cAMP.
Conclusion:
D-4F affects cholesterol efflux, cAMP level, and ABCA1 expression in macrophages, which is likely involved in the pathway of cAMP/PKA/ABCA1.
Insights
The apolipoprotein A-I mimetic peptide D-4F enhances cholesterol efflux in macrophages. This process involves increased cyclic AMP (cAMP) levels and ATP binding cassette transporter A1 (ABCA1) expression, suggesting a cAMP/PKA/ABCA1 pathway.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Apolipoprotein (apo) A-I plays a crucial role in reverse cholesterol transport.
- Dysregulation of cholesterol efflux is implicated in atherosclerosis.
- Apolipoprotein A-I mimetic peptides are being investigated for their therapeutic potential.
Purpose of the Study:
- To investigate the effect of the apo A-I mimetic peptide D-4F on cholesterol efflux in RAW264.7 macrophages.
- To elucidate the underlying mechanism of D-4F's action, focusing on cyclic AMP (cAMP) and ATP binding cassette transporter A1 (ABCA1).
Main Methods:
- RAW264.7 macrophages were treated with 8-bromo cAMP and oxidized low-density lipoprotein (ox-LDL).
- D-4F or protein kinase A (PKA) inhibitor H89 were added to assess their effects.
- Intracellular cAMP levels were measured using ELISA.
- ABCA1 mRNA and protein expression were quantified via real-time PCR and Western blot.
Main Results:
- D-4F significantly increased cholesterol efflux in a concentration- and time-dependent manner.
- D-4F treatment led to elevated intracellular cAMP levels and increased ABCA1 mRNA and protein expression.
- The effects of D-4F were enhanced by 8-bromo cAMP and partially attenuated by H89, indicating a role for the cAMP/PKA pathway.
Conclusions:
- D-4F effectively promotes cholesterol efflux from macrophages.
- The mechanism involves the cAMP/PKA/ABCA1 signaling pathway.
- D-4F represents a potential therapeutic agent for conditions associated with impaired cholesterol transport.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
Considering cholesterol and...
01:24Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents